U.S. Places Hold On J&J Vaccine Distribution

Possible blood-clotting side effect under investigation by FDA.

On Tuesday, U.S. health organizations announced that the Johnson & Johnson (J&J) vaccine should stop being administered temporarily. This announcement came as concerns of a possible blood-clotting side effect have been discovered. The Food and Drug Association (FDA) has begun an investigation of six women between the ages of 18 and 48 who experienced unusual clots after receiving the vaccine. 

Acting FDA Administrator Janet Woodcock said that she expects the pause on the distribution of the vaccine to only last a few days to allow the FDA to conduct an investigation. More than 6.8 million doses of the vaccine have been administered in the U.S., suggesting that the side effect is exceptionally rare. Health authorities reaffirmed that no adverse side effects have been found for the Pfizer and Moderna vaccines. 

As the Lord Leads, Pray with Us…

  • For the FDA as they determine the risks associated with the vaccine. 
  • That the president’s administration would have discernment in handling reactions from experimental therapies. 
  • That God would bring healing to those suffering from side effects from the vaccine. 

Sources: AP, NPR, NY Times


Back to top